Similar articles

• Binding of drugs to sera of patients with renal disease and liver disease.

  Matsushita Y, Eiki J, Tsukiori M, Suzuki T, Moriguchi I. Matsushita Y, et al. Chem Pharm Bull (Tokyo). 1987 Jan;35(1):308-14. doi: 10.1248/cpb.35.308. Chem Pharm Bull (Tokyo). 1987. PMID: 3594661 No abstract available.
• Therapeutic and toxic concentrations of more than 100 toxicologically significant drugs in blood, plasma, or serum: a tabulation.

  Baselt RC, Wright JA, Cravey RH. Baselt RC, et al. Clin Chem. 1975 Jan;21(1):44-62. Clin Chem. 1975. PMID: 1090394 Review. No abstract available.
• Therapeutic and toxic drug concentrations in post mortem blood: a six year study in the State of Maryland.

  Caplan YH, Ottinger WE, Crooks CR. Caplan YH, et al. J Anal Toxicol. 1983 Sep-Oct;7(5):225-30. doi: 10.1093/jat/7.5.225. J Anal Toxicol. 1983. PMID: 6645403
• [Blood concentrations in acute fatal poisoning. Experiences with forensic cases].

  Teige B, Fleischer E. Teige B, et al. Tidsskr Nor Laegeforen. 1983 Mar 10;103(7):679-85. Tidsskr Nor Laegeforen. 1983. PMID: 6868047 Norwegian. No abstract available.
• [Proposal of an analytical pathway for the treatment of poisonings--6--application of blood concentration to the evaluation of toxicity (2): tools for diagnosis and therapy].

  Fukumoto M. Fukumoto M. Chudoku Kenkyu. 2006 Oct;19(4):413-6. Chudoku Kenkyu. 2006. PMID: 17133985 Review. Japanese. No abstract available.